Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Contenu archivé le 2024-06-18

Detection of endpoints and biomarkers of repeated dose toxicity using in vitro systems

Objectif

Assessment of repeated dose toxicity is a standard requirement in human safety evaluation and relies on animal testing as no alternatives are currently accepted for regulatory purposes. An integrated research strategy for the replacement of animal tests needs to comprise the development of biomarkers of long-term toxicity in human target cells. To this aim, the DETECTIVE project will set up a screening pipeline of high content, high throughput as well as classical functional and “-omics” technologies to identify and investigate human biomarkers in cellular models for repeated dose in vitro testing. In view of industrial use in automated high throughput systems, essential questions of repeated dose toxicity such as stability and robustness of readouts will be investigated in a first phase. This will be the foundation for innovative biomarker development based on integration of multiple data streams derived from “-omics” readouts with traditional toxicological and histopathological endpoint evaluation. Toxicity pathways identified in “-omics” readouts can thus be further investigated by the functional readouts.
DETECTIVE will initially use human hepatic, cardiac and renal models as common target organs of repeated dose toxicity. Ultimately, the strategy for establishing biomarkers will also be applicable to other organs or organ systems affected by systemic toxicants. It is also expected that DETECTIVE will be able to define human toxicity pathways relevant for all organs.
Based on integrative statistical analysis, systematic verification and correlation with in vivo data, the most relevant, highly specific, sensitive and predictive biomarkers will be selected. Within DETECTIVE, partners from academia, industry and research will hence generate pathway- and evidence-based understanding of toxic effects, moving toxicology beyond descriptive science towards mechanism-based prediction.

Champ scientifique

Programme(s)

Thème(s)

Appel à propositions

FP7-HEALTH-2010-Alternative-Testing
Voir d’autres projets de cet appel

Régime de financement

CP-IP - Large-scale integrating project

Coordinateur

KLINIKUM DER UNIVERSITAET ZU KOELN
Contribution de l’UE
€ 1 092 420,01
Adresse
Kerpener Strasse 62
50937 Koeln
Allemagne

Voir sur la carte
Région
Nordrhein-Westfalen Köln Köln, Kreisfreie Stadt
Type d’activité
Higher or Secondary Education Establishments
Contact administratif
Jürgen Hescheler (Prof.)
Liens
Coût total
Aucune donnée

Participants (14)

Partager cette page

Télécharger

Dernière mise à jour: 26 Mai 2017

Mon livret

Permalink: https://cordis.europa.eu/project/id/266838/fr

European Union, 2024